08 Feb, 2022 CereVasc Receives FDA IDE Approval to Begin Initial Clinical Study of the eShunt® System for Patients with Normal Pressure Hydrocephalus Admin2023-11-06T21:21:09+00:00February 8th, 2022| Read More
